MTACU

MedTech Acquisition (MTACU)

MedTech Acquisition Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MTACU

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/01	06 : 02	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:MTACU	MedTech Acquisition Corporation
2024/05/01	06 : 01	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:MTACU	MedTech Acquisition Corporation
2024/05/01	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MTACU	MedTech Acquisition Corporation
2024/04/25	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MTACU	MedTech Acquisition Corporation
2024/04/25	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MTACU	MedTech Acquisition Corporation
2024/04/12	06 : 14	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:MTACU	MedTech Acquisition Corporation
2024/04/12	05 : 36	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:MTACU	MedTech Acquisition Corporation
2024/04/02	19 : 07	Edgar (US Regulatory)	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405	NASDAQ:MTACU	MedTech Acquisition Corporation
2024/04/01	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/15	08 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/15	08 : 22	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/15	08 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/15	08 : 16	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/15	08 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/15	08 : 12	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/15	08 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/15	08 : 05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/15	07 : 23	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/15	07 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/15	07 : 00	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/15	06 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/15	06 : 49	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/15	06 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/15	06 : 37	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/09	20 : 05	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/09	20 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/03	06 : 20	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/03	06 : 05	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/03	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MTACU	MedTech Acquisition Corporation
2023/08/02	20 : 06	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:MTACU	MedTech Acquisition Corporation